Non-Pharmacological Interventions in the Management of Dementia-Related Psychosis: A Systematic Review and Meta-Analysis
- PMID: 39112442
- DOI: 10.1002/gps.6129
Non-Pharmacological Interventions in the Management of Dementia-Related Psychosis: A Systematic Review and Meta-Analysis
Abstract
Objective: As populations age globally, there is an increasing prevalence of dementia, with an estimated 153 million living with dementia by 2050. Up to 70% of people with dementia experience dementia-related psychosis (D-RP). Antipsychotic medications are associated with many adverse effects in older people. This review aims to evaluate the evidence of non-pharmacological interventions in managing D-RP.
Method: The search of Medline, EMBASE, Web of Science, CINAHL, PsycINFO, and Cochrane included randomised controlled trials that evaluated non-pharmacological interventions. Data extraction and assessment of quality were assessed independently by two researchers. Heterogenous interventions were pooled using meta-analysis.
Results: A total of 18 articles (n = 2040 participants) were included and categorised into: sensory-, activity-, cognitive- and multi-component-orientated. Meta-analyses showed no significant impact in reducing hallucinations or delusions but person-centred care, cognitive rehabilitation, music therapy, and robot pets showed promise in single studies.
Conclusions and implications: Future interventions should be developed and evaluated with a specific focus on D-RP as this was not the aim for many of the included articles.
Keywords: care home; delusions; dementia; hallucinations; interventions; non‐pharmacological; nursing home; psychosis.
© 2024 The Author(s). International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd.
References
-
- World Health Organization, “WHO methods and data sources for life tablets 1990-2019,” (World Health Organization, 2019). https://cdn.who.int/media/docs/default‐source/gho‐documents/global‐healt....
-
- A. Nandi, N. Counts, S. Chen, et al., “Global and Regional Projections of the Economic Burden of Alzheimer’s Disease and Related Dementias From 2019 to 2050: A Value of Statistical Life Approach,” eClinicalMedicine 51 (2022): 101580, https://doi.org/10.1016/j.eclinm.2022.101580.
-
- The Lancet Public Health: Global Dementia Cases Set to Triple by 2050 Unless Countries Address Risk Factors (Seattle, Washington: Institute for Health Metrics and Evaluation), accessed November 5, 2023, https://www.healthdata.org/news‐events/newsroom/news‐releases/lancet‐pub...
-
- G. Naasan, S. M. Shdo, E. M. Rodriguez, et al., “Psychosis in Neurodegenerative Disease: Differential Patterns of Hallucination and Delusion Symptoms,” Brain 144, no. 3 (2021): 999–1012, https://doi.org/10.1093/brain/awaa413.
-
- L. Agüera‐Ortíz, G. M. Babulal, M. A. Bruneau, et al., “Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions,” Journal of Alzheimer's Disease 88, no. 4 (2022): 1203–1228, https://doi.org/10.3233/jad‐215483.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
